Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
22-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #483
advertisement
Eye
69
Showing records 1 to 25 |
Display all abstracts in
Eye
92402
Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
Mergen B
Eye
2021; 35: 3350-3357
92512
Outcome of a low-cost glaucoma drainage device with posterior chamber/pars plana insertion of the tube
Rajamani M
Eye
2021; 35: 901-912
92529
Clinical spectrum and treatment outcomes of patients with nanophthalmos
Rajendrababu S
Eye
2021; 35: 825-830
92450
Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Tsuchiya S
Eye
2021; 35: 919-928
92107
Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials
Pose-Bazarra S
Eye
2021; 35: 1551-1561
92262
Validation of a portable, non-mydriatic fundus camera compared to gold standard dilated fundus examination using slit lamp biomicroscopy for assessing the optic disc for glaucoma
Upadhyaya S
Eye
2022; 36: 441-447
92751
The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Ding J
Eye
2022; 36: 800-811
92601
Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Mushtaq Y
Eye
2022; 36: 555-563
92599
Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Marta A
Eye
2022; 36: 111-118
92467
Virtual clinics for glaucoma care - Patients' and clinicians' experiences and perceptions: a qualitative evaluation
Gunn PJG
Eye
2022; 36: 209-218
91909
Clinical features of microvasculature in subzones of parapapillary atrophy in myopic eyes: an OCT-angiography study
Hu X
Eye
2021; 35: 455-463
91957
Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Kim EW
Eye
2021; 35: 536-543
92601
Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Panchasara B
Eye
2022; 36: 555-563
91957
Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Park HS
Eye
2021; 35: 536-543
92751
The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Tecson IC
Eye
2022; 36: 800-811
92262
Validation of a portable, non-mydriatic fundus camera compared to gold standard dilated fundus examination using slit lamp biomicroscopy for assessing the optic disc for glaucoma
Agarwal A
Eye
2022; 36: 441-447
92467
Virtual clinics for glaucoma care - Patients' and clinicians' experiences and perceptions: a qualitative evaluation
Marks JR
Eye
2022; 36: 209-218
91909
Clinical features of microvasculature in subzones of parapapillary atrophy in myopic eyes: an OCT-angiography study
Shang K
Eye
2021; 35: 455-463
92599
Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Vieira R
Eye
2022; 36: 111-118
92402
Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
Ramsey DJ
Eye
2021; 35: 3350-3357
92107
Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials
López-Valladares MJ
Eye
2021; 35: 1551-1561
92599
Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Vieira R
Eye
2022; 36: 111-118
92450
Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Higashide T
Eye
2021; 35: 919-928
92512
Outcome of a low-cost glaucoma drainage device with posterior chamber/pars plana insertion of the tube
Ramamurthy C
Eye
2021; 35: 901-912
92529
Clinical spectrum and treatment outcomes of patients with nanophthalmos
Shroff S
Eye
2021; 35: 825-830
«
1
2
3
»
Issue
22-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement